the composition of the national centralized purchasing catalogue of the ninth batch of drugs
The national centralized purchasing catalogue of the ninth batch of drugs contains many kinds of drugs, and the selection of these drugs is usually based on their clinical needs, market supply and price level. The drugs in the catalogue cover many therapeutic fields, aiming at meeting the drug demand of patients.
second, the significance and purpose of national centralized procurement
the implementation of national centralized procurement policy aims at reducing the price of drugs and reducing the burden on patients through centralized procurement. Through large-scale procurement, we can increase the transparency of the drug market, promote market competition, and then promote the reasonable reduction of drug prices. In addition, national centralized procurement is also helpful to optimize the drug supply structure, improve the stability of drug supply and ensure the safety of patients' medication.
the impact of the third and ninth national centralized purchasing catalogue of drugs
The publication and implementation of the ninth national centralized purchasing catalogue of drugs will have a far-reaching impact on the drug market. First of all, it will help to further reduce the price of drugs, so that patients can buy the drugs they need at lower prices. Secondly, national centralized procurement will promote the standardized development of the drug market and reduce unfair competition and price fraud. Finally, national centralized procurement will also promote the innovation and development of the pharmaceutical industry and encourage enterprises to develop more high-quality and efficient drugs.
To sum up:
The national centralized purchasing catalogue of the ninth batch of drugs is an important policy implemented by the state to reduce drug prices and reduce the burden on patients. The publication and implementation of this catalogue will help to optimize the drug supply structure, improve the stability of drug supply, and promote the standardized development of drug market. At the same time, national centralized procurement will also promote the innovation and development of the pharmaceutical industry and provide patients with more high-quality and efficient drug choices.
Legal basis:
Article 55 of the Drug Administration Law of the People's Republic of China
stipulates:
The state practices a centralized drug procurement system. For clinically necessary drugs with small dosage, fixed-point production, centralized procurement and unified distribution shall be implemented; Drugs with large clinical dosage, high purchase amount and full competition shall be purchased by public bidding.
Article 3 of the Price Law of the People's Republic of China
stipulates:
The state practices and gradually improves the mechanism that prices are mainly set by the market under macroeconomic regulation and control. The formulation of prices should conform to the law of value. Most goods and services are subject to market-regulated prices, and very few goods and services are subject to government guidance or government pricing.